Azithromycin dihydrate
CA 1314876 C · Owner: Nepveux, Kevin Michael · Inventors: Nepveux, Kevin Michael; Allen, Douglas John Meldrum
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are crystalline azithromycin (9-deoxo-9a-aza- 9a-methyl-9a-homoerythromycin) dihydrate and a process for producing the same. The crystalline dihydrate is non-hygroscopic and is easier to prepare and maintain the product in a form having a constant reproducible water content then hygroscopic monohydrate. The dihydrate is produced by crystallization from tetrahydrofuran and aliphatic hydrocarbon in the presence of a sufficient amount of water.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted March 23, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended March 23, 2010.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.